Open AccessSystemic Therapy for Invasive Bladder Cancer: The Value Proposition
Author(s) -
Raghavan Derek
Publication year - 2016
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2016-0074
Subject(s) - medicine , vinblastine , bladder cancer , cisplatin , methotrexate , doxorubicin , chemotherapy , oncology , urothelial cancer , cancer
Neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy followed by definitive local treatment should be the treatment of choice for otherwise healthy and robust patients with T2b–T4 invasive bladder cancer.